Subjects With Resectable and Localized Gastric Cancer

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Subjects With Resectable and Localized Gastric Cancer trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

Active — Not RecruitingPhase 2

NCT04196465

Phase II Study of Neoadjuvant Immune Checkpoint Inhibitor in Patients With Resectable Gastrointestinal Cancers

This is a phase II, open-label, prospective single-centered study. Subjects who meet the inclusion/exclusion criteria will be allocated to appropriate cohorts:…

South Korea48 participantsStarted 2019-09-09

Treatment: IMC-001